A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).
Inclusion Criteria:-
Exclusion Criteria:
Participate-In-This-Study1@its.jnj.com844-434-4210
Beverly Hills, California 90211, United States
Hemet, California 92543, United States
Torrance, California 90502, United States
Voorhees Township, New Jersey 08043, United States
Roanoke, Virginia 24011, United States
CABA, C1426BOS, Argentina
Ciudad de Buenos Aires, C1055, Argentina
Ciudad de Buenos Aires, C1427, Argentina
Porto Alegre, 90610 000, Brazil
Ribeirão Preto, 14051140, Brazil
São José do Rio Preto, 15090 000, Brazil
Vitória, 29055 450, Brazil
Sofia, 1606, Bulgaria
Varna, 9010, Bulgaria
Cheng Du Shi, 610041, China
Hangzhou, 311608, China
Luoyang, 471003, China
Karvina Frystat, 733 01, Czechia
Athens, 12461, Greece
Shinjuku- Ku, 162-8655, Japan
Tokyo, 113 8677, Japan
Istanbul, 34899, Turkey (Türkiye)
Greater London, SE1 9RT, United Kingdom